Ibrilparant is a LPA1 receptor antagonist with an IC 50 of 0.00753 μM. Ibrilparant exhibits LPA1 calcium flux antagonistic activity, with an IC 50 of 3.02 nM. Ibrilparant can be used in research related to various diseases such as cancer and inflammatory diseases.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。